Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
Hypopituitarism and cardiovascular risk
ID
Kraljević, Ivana
(
Author
),
ID
Solak, Mirsala
(
Author
),
ID
Mandić, Ante
(
Author
),
ID
Mlekuš, Katarina
(
Author
),
ID
Raičević, Maja
(
Author
),
ID
Divanović Slato, Anida
(
Author
),
ID
Kovačević, Zlata
(
Author
),
ID
Muzurović, Emir
(
Author
)
PDF - Presentation file,
Download
(626,41 KB)
MD5: CCDA4D689CC20F565393AE945F1426C8
URL - Source URL, Visit
https://journals.sagepub.com/doi/10.1177/10742484251332398
Image galllery
Abstract
Hypopituitarism, resulting from a partial or complete deficiency of anterior or posterior pituitary hormones, is associated with increased cardiovascular (CV) morbidity and mortality. This heterogeneous endocrinological disorder may arise from various etiologies, including genetic mutations, pituitary tumors, traumatic brain injury, and autoimmune diseases. Hypopituitarism often results in multiple endocrine deficits that contribute to metabolic dysregulation characterized by insulin resistance, dyslipidemia, and increased visceral adiposity, all known risk factors for CV disease (CVD). Additionally, the presence of chronic inflammation and endothelial dysfunction further increases the risk of CVD in these patients. While standard hormone replacement therapy (HRT) is crucial for restoring hormonal balance, it can sometimes have adverse metabolic effects that can exacerbate atherosclerosis and CVD. Emerging evidence suggests that optimizing HRT regimens and addressing specific hormone deficiencies, such as growth hormone and cortisol, may reduce these risks and improve CV outcomes. This review comprehensively analyzes the etiology, pathophysiological mechanisms underlying CV risk in anterior pituitary dysfunction, and treatment strategies to mitigate CV morbidity and mortality in patients with hypopituitarism.
Language:
English
Keywords:
hypopituitarism
,
cardiovascular risk
,
cardiovascular disease
,
GH deficiency
,
hormone replacement therapy
Work type:
Article
Typology:
1.02 - Review Article
Organization:
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2025
Number of pages:
22 str.
Numbering:
Vol. 30
PID:
20.500.12556/RUL-182308
UDC:
616.1
ISSN on article:
1940-4034
DOI:
10.1177/1074248425133239
COBISS.SI-ID:
275553027
Publication date in RUL:
07.05.2026
Views:
247
Downloads:
164
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Journal of cardiovascular pharmacology and therapeutics
Publisher:
Sage
ISSN:
1940-4034
COBISS.SI-ID:
3177236
Licences
License:
CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:
http://creativecommons.org/licenses/by-nc/4.0/
Description:
A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.
Secondary language
Language:
Slovenian
Keywords:
hipopituitarizem
,
kardiovaskularno tveganje
,
kardiovaskularna bolezen
,
pomanjkanje rastnega hormona
,
nadomestno hormonsko zdravljenje
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back